BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu KX, Joshi S. "Re-educating" Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma. Front Immunol 2020;11:1947. [PMID: 32983125 DOI: 10.3389/fimmu.2020.01947] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Wang X, Wang W, Chai W, Song W, Zhang H, Mou W, Pei M, Su Y, Ma X, Gui J. Interleukin-15 enhanced the survival of human γδT cells by regulating the expression of Mcl-1 in neuroblastoma. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-022-00942-5] [Reference Citation Analysis]
2 Sun J, Park C, Guenthner N, Gurley S, Zhang L, Lubben B, Adebayo O, Bash H, Chen Y, Maksimos M, Muz B, Azab AK. Tumor-associated macrophages in multiple myeloma: advances in biology and therapy. J Immunother Cancer 2022;10:e003975. [DOI: 10.1136/jitc-2021-003975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Ishfaq M, Pham T, Beaman C, Tamayo P, Yu AL, Joshi S. BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma. Cancers (Basel) 2021;13:817. [PMID: 33669187 DOI: 10.3390/cancers13040817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gao J, Liang Y, Wang L. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy. Front Immunol 2022;13:888713. [DOI: 10.3389/fimmu.2022.888713] [Reference Citation Analysis]
5 Pelosi A, Fiore PF, Di Matteo S, Veneziani I, Caruana I, Ebert S, Munari E, Moretta L, Maggi E, Azzarone B. Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms' Tumors. Cancers (Basel) 2021;13:2374. [PMID: 34069127 DOI: 10.3390/cancers13102374] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Salemi F, Alam W, Hassani MS, Hashemi SZ, Jafari AA, Mirmoeeni SMS, Arbab M, Mortazavizadeh SMR, Khan H. Neuroblastoma: Essential genetic pathways and current therapeutic options. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175030] [Reference Citation Analysis]
7 Tang XX, Shimada H, Ikegaki N. Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma. Front Immunol 2021;12:650427. [PMID: 33968044 DOI: 10.3389/fimmu.2021.650427] [Reference Citation Analysis]
8 Fuertes MB, Domaica CI, Zwirner NW. Leveraging NKG2D Ligands in Immuno-Oncology. Front Immunol 2021;12:713158. [PMID: 34394116 DOI: 10.3389/fimmu.2021.713158] [Reference Citation Analysis]
9 Frosch J, Leontari I, Anderson J. Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment. Cancers (Basel) 2021;13:1743. [PMID: 33917501 DOI: 10.3390/cancers13071743] [Reference Citation Analysis]
10 Jing Chu. Development of a prognostic model for children with neuroblastoma based on necroptosis-related genes. Front Genet 2022;13:947000. [DOI: 10.3389/fgene.2022.947000] [Reference Citation Analysis]
11 Asiry S, Kim G, Filippou PS, Sanchez LR, Entenberg D, Marks DK, Oktay MH, Karagiannis GS. The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy. Front Immunol 2021;12:654877. [PMID: 33927723 DOI: 10.3389/fimmu.2021.654877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Gunaydin G. CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion. Front Oncol 2021;11:668349. [PMID: 34336660 DOI: 10.3389/fonc.2021.668349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sha Y, Han L, Sun B, Zhao Q. Identification of a Glycosyltransferase Signature for Predicting Prognosis and Immune Microenvironment in Neuroblastoma. Front Cell Dev Biol 2021;9:769580. [PMID: 35071226 DOI: 10.3389/fcell.2021.769580] [Reference Citation Analysis]
14 Tang XX, Shimada H, Ikegaki N. Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma. Genes Immun 2022;23:129-40. [PMID: 35525858 DOI: 10.1038/s41435-022-00172-w] [Reference Citation Analysis]
15 Kang W, Hu J, Zhao Q, Song F. Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma. Front Cell Dev Biol 2021;9:731380. [PMID: 34746127 DOI: 10.3389/fcell.2021.731380] [Reference Citation Analysis]